| Literature DB >> 30001435 |
Ruben Dario Arroyo-Olarte1, Laura Thurow1, Vera Kozjak-Pavlovic2, Nishith Gupta1.
Abstract
The birth and subsequent evolution of optogenetics has resulted in an unprecedented advancement in our understanding of the brain. Its outstanding success does usher wider applications; however, the tool remains still largely relegated to neuroscience. Here, we introduce selected aspects of optogenetics with potential applications in infection biology that will not only answer long-standing questions about intracellular pathogens (parasites, bacteria, viruses) but also broaden the dimension of current research in entwined models. In this essay, we illustrate how a judicious integration of optogenetics with routine methods can illuminate the host-pathogen interactions in a way that has not been feasible otherwise.Entities:
Mesh:
Year: 2018 PMID: 30001435 PMCID: PMC6042787 DOI: 10.1371/journal.ppat.1007046
Source DB: PubMed Journal: PLoS Pathog ISSN: 1553-7366 Impact factor: 6.823
Exemplary optogenetic tools to study specific paradigms of the pathogen–host interactions.
| Protein family | Optogenetic tools | Parasite or host cell | Bacteria or host cell | Virus-infected host cell |
|---|---|---|---|---|
| (potential usage) | (potential usage) | (potential usage) | ||
| Channelrhodopsin | Reversible perturbation of ion homeostasis in parasite and host cells; Organelle-specific ion uncoupling | Study the relevance of K+ homeostasis against toxic electrophilic compounds in gram-negative bacteria; Modulation of mitochondrial function to study the pathogen’s dependence on the organelle (e.g., | Study of subcellular ion pools in host organelles; Functions of viral membrane channels (viroporins) during lifecycle | |
| PACR, light-activated GPCRs/RTKs, OptoSTIM1, GCaMP1-6, YC-Nano | Manipulation of calcium signaling; Examining of Ca2+ dynamics/flux between organelles during lytic cycle | Oscillation and detection of calcium levels (e.g., | Conditional manipulation of virus-induced perturbation of host-cell Ca2+ to promote viral replication and inhibit immune response | |
| bPAC and mPAC for cAMP, BeCyclOp (RhoGC) and bPGC (BlgC) for cGMP, BphS for c-di-GMP, Flamindo1-3 (cAMP), cGi and FlincG1-3 (cGMP), RNA-based sensor (c-di-GMP) | Induction and concurrent monitoring of cNMP signaling during lytic cycle and stage differentiation of parasites | Modulation of transcription and mitochondrial function during | Alteration of cAMP-dependent resistance to | |
| LAPD (cAMP, cGMP), BlrP1 and EB1 (c-di-GMP) | Knockdown of cNMP signaling during lytic cycle and stage differentiation ( | Repression of cyclic nucleotide signaling in conjunction with activation by nucleotide cyclase (see above) | Modulation of virus production and pathogen phagocytosis by infected cells through cAMP/ cGMP (HIV-1, Measles virus) | |
| LACE, LOV2-ODC/B-LID degron, LITE | Activation or repression of proteins in parasite or host cell; Alteration of epigenetic states | Bi-directional control of gene expression in bacteria or host cell | Regulation of immunity-related genes & gene editing of viral proteins | |
| KillerRed (superoxide), miniSOGs (singlet oxygen) | Regulation of ROS-mediated killing and host oxidative stress on | Induction and detection of ROS during infection, e.g., | Role of ROS induction (plant virus, HIV-1) | |
| CRY2/CIBN fusion coupled to inositol phosphatase | Phosphoinositide signaling during replication and stage differentiation | Alteration of host phosphoinositide levels during infection (e.g., induction of phagocytosis by | Control of viral attachment and fusion to host-cell plasma membrane; Lipid rafts as platform for viral particle assembly | |
| (1) CRY2/CIBN fusion to Cre system | Light-activated Cre-mediated recombination to delete virulence factors ( | Control of Rho/Ras GTPase signaling to alter host actin-cytoskeleton polymerization (e.g., | (1) Deletion of integrated proviral DNA (HIV-1) | |
| Lact-C2-GFP (PtdSer), PKCδ-C1 and PKD-C1 (diacylglycerol), PASS (PtdOH), small soluble metabolite sensors (sugars, amino acids, lactate | Monitoring of lipid trafficking, drug inhibition and metabolic transport in parasitized cells | Monitoring of lipid trafficking, drug inhibition, and metabolic transport in infected cells | Monitoring of lipid trafficking, drug inhibition, and metabolic transport in virus-infected cells; Visualization of lipid rafts during virus assembly | |
| pHluorin, pHoenix and SRpHi1-4 (pH), TrxRFP1 and Peredox (redox), GEVIs (voltage), NOA-1 (nitric oxide), OptoGEF-RhoA (contractile forces) | Modulation/monitoring of physicochemical parameters in pathogen or host cell organelles | Modulation/monitoring of physicochemical parameters in pathogen or host cell organelles | Modulation/monitoring of physicochemical parameters in host cell organelles |
Selected abbreviations: CIBN, N-terminus of calcium and integrin-binding protein 1; cNMP, cyclic nucleotide monophosphate; GECA, genetically encoded calcium actuators; GECI, gene-encoded calcium indicator; GFP, green fluorescent protein; GPCR, G protein-coupled receptor; LACE, light-activated CRISPR-Cas9 effector; LAPD, light-activated phosphodiesterase; LITE, light-inducible transcriptional effectors; PACR, photoactivable Ca2+ releaser; PASS, phosphatidic acid biosensor with superior sensitivity; PIF, phytochrome interacting factor; PKD, protein kinase D; ROS, reactive oxygen species
Fig 1Optogenetic tools proposed for infection biology.
(A) Scheme of selected opto-tools to modulate and/or monitor second messengers, ions, and pH. Indicated proteins can be targeted to the prokaryotic/eukaryotic pathogens or even to the organelle of choice in the host cell by means of corresponding sorting signal sequence. For simplicity, only few selected organelles of a typical eukaryotic cell are shown to illustrate the concept. The actual proteins for individual applications may differ in their domain structure, mode of action, and light absorption. (B) Light-regulated methods to control gene expression, protein stability, and phosphoinositide signaling, as well as biosensors of lipids and lipid-derived metabolites. Upon illumination, an RNA-guided dCas9 binds to a CRY2-VP64 transactivation domain, which in turn allows otherwise repressed transcription of a gene. LoxP-mediated recombination at a target locus is achieved by a photo-dimerizable CRE recombinase. Light-activated degron: The protein of interest is fused to a photosensitive LOV2 and a proteasome targeting cODC1 domain. Optically induced degradation is facilitated by a conformational shift in the latter 2 domains. CRY2/CIBN fusion to inositol phosphatase enables a concurrent modulation and evaluation of phosphoinositide metabolism. Lipid-binding domains Lact-C2 and PKCδ-C1 fused to GFP allow fluorescent detection of subcellular PtdSer and DAG, respectively. Equally, a fusion of CFP and Venus with IP3-binding motif permits a FRET-based monitoring of IP3. Further details on indicated proteins can be found in S1 Appendix and references therein. CFP, cyan-fluorescent protein; CIBN, N-terminus of CIB1; CRE, cyclization recombinase; DAG, diacylglycerol; FRET, fluorescence-resonance energy transfer; GFP, green fluorescent protein; LACE, light-activated CRISPR-Cas9 effector.
Fig 2Asexual reproduction of prototypical intracellular pathogens within a mammalian host cell.
(A) Strategic stages during the development of 2 parasitic protists (Toxoplasma gondii, Trypanosoma cruzi) and a bacterium (Chlamydia). Note that only selected features are highlighted. The shared events include invasion, proliferation, and egress. The tachyzoite stage of T. gondii actively invades host cells, reorders several organelles (not depicted for simplicity), replicates by endodyogeny in a nonfusogenic vacuole, and then exits by lysing the vacuolar and host membranes. Cyclic nucleotides (cAMP, cGMP) and ions (Ca2+, K+) play very important roles during the lytic cycle. The trypomastigote stage of T. cruzi enters the host cell by recruiting lysosomes and then escapes into cytoplasm (mediated by TcTox), where they reproduce asexually as amastigotes. Among others, Ca2+, pH, and ROS are major factors during T. cruzi infection. The EBs of Chlamydia are endocytosed into membranous vacuoles, which fuse to form an inclusion, the replicative compartment. Later on, they differentiate into larger metabolically active RBs, which replicate by binary fission before converting back to EBs. Similar to tachyzoites, Chlamydia is known to intercept/recruit many host organelles, such as Golgi, lipid droplets, and endolysosomes, probably for acquiring nutrients. Again, cAMP and cGMP, along with prokaryote-specific c-di-GMP, control the stage differentiation and STING-mediated modulation of host immunity genes, respectively. (B) Abridged lifecycle of viruses infecting a host cell. Key second messengers, ions, and metabolites potentially regulatable or detectable by optogenetic means are shown in relation to specific events during the course of infection. In particular, calcium, pH, ROS, and phosphoinositide signaling regulate a repertoire of phenomena. For additional details, please refer to the table outlining different tools, pathogens, and paradigms (Table 1). EBs, elementary bodies; RBs, reticulate bodies; ROS, reactive oxygen species; STING, stimulator of interferon genes; TcTox, T. cruzi toxin (hemolysin).